Author
Listed:
- Yanlin Jia
(Merck Research Lab)
- Ken Chen
(Daping Hospital, The Third Military Medical University, Chongqing Institute of Cardiology)
- Peihui Lin
(Davis Heart and Lung Research Institute, The Ohio State University
Robert Wood Johnson Medical School)
- Gissela Lieber
(Merck Research Lab)
- Miyuki Nishi
(Kyoto University Graduate School of Pharmaceutical Sciences)
- Rosalie Yan
(TRIM-edicine, Inc.)
- Zhen Wang
(Daping Hospital, The Third Military Medical University, Chongqing Institute of Cardiology)
- Yonggang Yao
(Daping Hospital, The Third Military Medical University, Chongqing Institute of Cardiology)
- Yu Li
(Daping Hospital, The Third Military Medical University, Chongqing Institute of Cardiology)
- Bryan A. Whitson
(Davis Heart and Lung Research Institute, The Ohio State University)
- Pu Duann
(Davis Heart and Lung Research Institute, The Ohio State University)
- Haichang Li
(Davis Heart and Lung Research Institute, The Ohio State University)
- Xinyu Zhou
(Davis Heart and Lung Research Institute, The Ohio State University)
- Hua Zhu
(Davis Heart and Lung Research Institute, The Ohio State University
Robert Wood Johnson Medical School)
- Hiroshi Takeshima
(Kyoto University Graduate School of Pharmaceutical Sciences)
- John C. Hunter
(Merck Research Lab)
- Robbie L. McLeod
(Merck Research Lab)
- Noah Weisleder
(Robert Wood Johnson Medical School
TRIM-edicine, Inc.
Davis Heart and Lung Research Institute, The Ohio State University)
- Chunyu Zeng
(Daping Hospital, The Third Military Medical University, Chongqing Institute of Cardiology)
- Jianjie Ma
(Davis Heart and Lung Research Institute, The Ohio State University
Robert Wood Johnson Medical School
TRIM-edicine, Inc.)
Abstract
Injury to lung epithelial cells has a role in multiple lung diseases. We previously identified mitsugumin 53 (MG53) as a component of the cell membrane repair machinery in striated muscle cells. Here we show that MG53 also has a physiological role in the lung and may be used as a treatment in animal models of acute lung injury. Mice lacking MG53 show increased susceptibility to ischaemia–reperfusion and overventilation-induced injury to the lung when compared with wild-type mice. Extracellular application of recombinant human MG53 (rhMG53) protein protects cultured lung epithelial cells against anoxia/reoxygenation-induced injuries. Intravenous delivery or inhalation of rhMG53 reduces symptoms in rodent models of acute lung injury and emphysema. Repetitive administration of rhMG53 improves pulmonary structure associated with chronic lung injury in mice. Our data indicate a physiological function for MG53 in the lung and suggest that targeting membrane repair may be an effective means for treatment or prevention of lung diseases.
Suggested Citation
Yanlin Jia & Ken Chen & Peihui Lin & Gissela Lieber & Miyuki Nishi & Rosalie Yan & Zhen Wang & Yonggang Yao & Yu Li & Bryan A. Whitson & Pu Duann & Haichang Li & Xinyu Zhou & Hua Zhu & Hiroshi Takeshi, 2014.
"Treatment of acute lung injury by targeting MG53-mediated cell membrane repair,"
Nature Communications, Nature, vol. 5(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5387
DOI: 10.1038/ncomms5387
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5387. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.